197 related articles for article (PubMed ID: 11143762)
21. Dyslipidemia in diabetes mellitus.
Yoshino G; Hirano T; Kazumi T
Diabetes Res Clin Pract; 1996 Jun; 33(1):1-14. PubMed ID: 8877270
[TBL] [Abstract][Full Text] [Related]
22. Modification of lipoprotein metabolism and function driving atherogenesis in diabetes.
Luciani L; Pedrelli M; Parini P
Atherosclerosis; 2024 Jul; 394():117545. PubMed ID: 38688749
[TBL] [Abstract][Full Text] [Related]
23. Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis.
Reaven GM
Metabolism; 1987 Feb; 36(2 Suppl 1):1-8. PubMed ID: 3807791
[TBL] [Abstract][Full Text] [Related]
24. Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins.
Dallinga-Thie GM; Dullaart RP; van Tol A
Curr Opin Lipidol; 2007 Jun; 18(3):251-7. PubMed ID: 17495597
[TBL] [Abstract][Full Text] [Related]
25. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome.
Grundy SM
Am J Cardiol; 1999 May; 83(9B):25F-29F. PubMed ID: 10357572
[TBL] [Abstract][Full Text] [Related]
26. Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors.
Reasner CA
J Cardiovasc Pharmacol; 2008 Aug; 52(2):136-44. PubMed ID: 18670366
[TBL] [Abstract][Full Text] [Related]
27. Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.
Qamar A; Khetarpal SA; Khera AV; Qasim A; Rader DJ; Reilly MP
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1880-8. PubMed ID: 26069232
[TBL] [Abstract][Full Text] [Related]
28. Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes.
Sheu WH; Jeng CY; Young MS; Le WJ; Chen YT
Am J Med Sci; 2000 Feb; 319(2):84-8. PubMed ID: 10698091
[TBL] [Abstract][Full Text] [Related]
29. [Relation between insulin resistance and small, dense lipoproteins with low density and the development of atherosclerosis in type 2 diabetes mellitus].
Fábryová L; Cagán S
Bratisl Lek Listy; 1998; 99(3-4):138-45. PubMed ID: 9919742
[TBL] [Abstract][Full Text] [Related]
30. Diabetic dyslipidaemia.
Erkelens DW
Eur Heart J; 1998 Jul; 19 Suppl H():H27-40. PubMed ID: 9717062
[TBL] [Abstract][Full Text] [Related]
31. Lipid abnormalities in insulin resistant states.
Watson KE; Horowitz BN; Matson G
Rev Cardiovasc Med; 2003; 4(4):228-36. PubMed ID: 14668690
[TBL] [Abstract][Full Text] [Related]
32. Bariatric surgery as a model to explore the basis and consequences of the Reaven hypothesis: Small, dense low-density lipoprotein and interleukin-6.
Adam S; Liu Y; Siahmansur T; Ho JH; Dhage SS; Yadav R; New JP; Donn R; Ammori BJ; Syed AA; Malik RA; Soran H; Durrington PN
Diab Vasc Dis Res; 2019 Mar; 16(2):144-152. PubMed ID: 31014098
[TBL] [Abstract][Full Text] [Related]
33. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
[TBL] [Abstract][Full Text] [Related]
34. Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile.
Dullaart RP; Constantinides A; Perton FG; van Leeuwen JJ; van Pelt JL; de Vries R; van Tol A
J Clin Endocrinol Metab; 2011 Apr; 96(4):1077-84. PubMed ID: 21252249
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia.
Ayyobi AF; Brunzell JD
Am J Cardiol; 2003 Aug; 92(4A):27J-33J. PubMed ID: 12957324
[TBL] [Abstract][Full Text] [Related]
36. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
37. Statins and diabetes.
Carmena R; Betteridge DJ
Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
[TBL] [Abstract][Full Text] [Related]
38. Postprandial triglyceride metabolism in diabetes mellitus.
Georgopoulos A
Clin Cardiol; 1999 Jun; 22(6 Suppl):II28-33. PubMed ID: 10376194
[TBL] [Abstract][Full Text] [Related]
39. [Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism].
Krone W; Müller-Wieland D; Wirth H
Fortschr Med; 1992 Dec; 110(34):645-8. PubMed ID: 1483617
[TBL] [Abstract][Full Text] [Related]
40. Insulin resistance syndrome and type 2 diabetes mellitus.
Erkelens DW
Am J Cardiol; 2001 Oct; 88(7B):38J-42J. PubMed ID: 11595198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
